{
    "Allele Frequency": "0.032", 
    "Build 37 Chromosome": "chr7", 
    "Build 37 Position": "142655008", 
    "Build 37 Variant Allele": "A", 
    "Build37 coordinates:": [], 
    "Clinical Importance": "Low", 
    "Condition Tags": [
        "Blood"
    ], 
    "Evidence": "Uncertain", 
    "Gene Symbol": "KEL", 
    "Impact": "Benign", 
    "Inheritance": "Dominant", 
    "PMID Count": 1, 
    "PMID List": [
        "7849312"
    ], 
    "Scores": {
        "Case/Control": "5", 
        "Computational": null, 
        "Familial": "5", 
        "Functional": "1", 
        "Penetrance": null, 
        "Severity": "0", 
        "Treatability": "2"
    }, 
    "Summary": "This variant is also known as Kell or K1 or K (capitalized) in the Kell antigen system. K1-negative mothers (carrying no copies of this variant) carrying K1-positive fetuses (heterozygous or homozygous) are at risk for hemolytic disease of the newborn. About 9% of caucasians carry one or two copies of K1.", 
    "URL": "http://evidence.pgp-hms.org/KEL-T193M", 
    "Variant Name": "KEL-T193M", 
    "Variant Page": "http://evidence.pgp-hms.org/KEL-T193M", 
    "dbSNP IDs": [
        "rs8176058"
    ]
}